MARRA, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.327
EU - Europa 12.447
AS - Asia 2.785
OC - Oceania 191
AF - Africa 103
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 35.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.277
RU - Federazione Russa 4.164
PL - Polonia 2.819
IT - Italia 1.425
IE - Irlanda 1.303
SE - Svezia 1.066
SG - Singapore 807
HK - Hong Kong 750
CN - Cina 530
UA - Ucraina 514
DE - Germania 383
FI - Finlandia 266
IN - India 242
GB - Regno Unito 232
AU - Australia 188
JO - Giordania 170
ID - Indonesia 95
CH - Svizzera 66
VN - Vietnam 63
TR - Turchia 62
CI - Costa d'Avorio 56
CA - Canada 49
FR - Francia 47
NL - Olanda 43
BE - Belgio 38
ES - Italia 29
SC - Seychelles 27
RO - Romania 17
EG - Egitto 13
PK - Pakistan 13
KR - Corea 9
MK - Macedonia 8
EU - Europa 7
JP - Giappone 6
PH - Filippine 6
AL - Albania 5
BD - Bangladesh 5
TH - Thailandia 5
BR - Brasile 4
IL - Israele 4
TW - Taiwan 4
IQ - Iraq 3
LT - Lituania 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
AR - Argentina 2
AT - Austria 2
BG - Bulgaria 2
EE - Estonia 2
LB - Libano 2
NG - Nigeria 2
PT - Portogallo 2
RS - Serbia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
Totale 35.868
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.060
Warsaw 2.818
Fairfield 2.459
Dublin 1.302
Chandler 1.260
Ashburn 1.186
Woodbridge 1.085
Seattle 989
Cambridge 946
Houston 842
Jacksonville 789
Wilmington 785
Singapore 654
Ann Arbor 482
Hong Kong 468
Altamura 417
Lawrence 417
Princeton 332
Florence 306
Boston 256
Mumbai 194
Boardman 189
Melbourne 183
Moscow 177
Beijing 165
San Diego 136
Buffalo 124
Medford 118
Shanghai 100
Jakarta 92
Milan 75
Kent 65
Bern 59
Los Angeles 57
Abidjan 56
Izmir 55
New York 55
Norwalk 54
Dong Ket 49
Rome 40
Helsinki 39
Brussels 38
Auburn Hills 34
London 34
Hillsboro 33
Toronto 33
Yubileyny 33
Falls Church 30
Barcelona 28
Andover 27
Frankfurt Am Main 23
Guangzhou 22
Phoenix 22
Dearborn 21
Pune 21
Bremen 20
West Jordan 18
Ottawa 14
Verona 14
Nanjing 11
Redwood City 11
Lappeenranta 10
Naples 10
Timisoara 10
Hangzhou 9
Islamabad 9
L’Aquila 9
Tappahannock 9
Falkenstein 8
Frankfurt am Main 8
Laurel 8
Munich 8
Seoul 8
Wuhan 8
Bagno a Ripoli 7
Bologna 7
Washington 7
Catania 6
Chiswick 6
Fiesole 6
Fuzhou 6
Naaldwijk 6
Prato 6
San Mateo 6
Arezzo 5
Bangkok 5
Cairo 5
Chennai 5
Chicago 5
Grosseto 5
Kunming 5
Manchester 5
New Bedfont 5
Perugia 5
Redmond 5
Saint Petersburg 5
Trumbull 5
Amsterdam 4
Brescia 4
Castelliri 4
Totale 25.676
Salva come PNG Salva come JPEG
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 280
Extracellular signal-regulated kinases modulate capacitation of human spermatozoa. 280
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 273
Molecular pathogenesis of NASH 272
Transient Hepatic Parenchymal Enhancement detected at dynamic imaging: A short instruction manual for the clinician. 271
Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A 265
Guanosine 3’: 5’-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats 264
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 263
Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells. 263
A role of resistin as a mediator of hepatic inflammation and oxidative stress 254
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 253
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 252
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 251
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 250
Phosphatidylinositol 3-kinase inhibition enhances human sperm motility. 244
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 236
Acute on chronic liver failure: From pathophysiology to clinical management. 233
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 228
Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells 215
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 211
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 204
Challenges of advanced hepatocellular carcinoma 198
Rapid and sound assessment of well-being within a multi-dimensional approach: The Well-being Numerical Rating Scales (WB-NRSs) 184
Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells. 183
Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. 183
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 170
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 159
c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. 159
LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling 158
Acute viral hepatitis increases liver stiffness values measured by transient elastography 157
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 154
Delayed Identification by CT of Parenchymal Changes Induced by Ligation of a Portal Vein Branch in the Rat-Preliminary Report 153
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 151
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 151
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 150
MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells 150
The role of stroma in cholangiocarcinoma: The intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium 148
A large rheumatoid nodule mimicking hepatic malignancy 147
Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. 147
Angiotensin II upregulates renin-angiotensin system in human isolated T-lymphocytes 146
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 144
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 144
Adipokines and redox signaling: impact on fatty liver disease 144
Machine Perfusion of the Pancreas: What Can We Learn from five Decades of Experimental Studies? 142
Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. 142
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 142
NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell (HSC) activation 141
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. 141
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 140
Modulation of liver fibrosis by adipokines. 140
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 140
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 139
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 138
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 138
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. 137
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 137
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 137
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 136
Mononuclear cells in liver fibrosis 136
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 135
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 135
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 134
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. 133
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 132
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 131
The role of adipokines in liver fibrosis 131
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 131
Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. 131
CD14+CD34(low) cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors 131
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 130
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 129
Screening of distress among hospitalized patients in a department of internal medicine. 129
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 129
ADMA correlates with portal pressure in patients with compensated cirrhosis. 128
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 128
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 127
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 127
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 126
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 126
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 126
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 126
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 125
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. 124
Fatty acids regulate the biology of cholangiocarcinoma cells 124
Adipokines in liver diseases. 123
Molecular mechanisms of hepatic fibrosis in non-alcoholicsteatohepatitis. 123
Fibrosis in alcoholic and nonalcoholic steatohepatitis. 123
SALLuting a new biomarker in hepatocellular carcinoma. 123
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 122
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 122
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 122
Torasemide in the treatment of patients with cirrhosis and ascites. 121
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 120
SEX STEROIDS AND ODORANTS MODULATE GONADOTROPIN-RELEASING HORMONE SECRETION IN PRIMARY CULTURES OF HUMAN OLFACTORY CELLS. 120
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 120
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 119
Role of Adipocytokines in Hepatic Fibrosis. 119
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 119
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 119
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 118
Totale 16.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.897 0 0 0 0 0 0 616 753 581 361 464 122
2020/20213.745 317 301 349 381 140 377 173 396 272 522 256 261
2021/20222.231 100 177 159 70 75 108 99 128 208 125 391 591
2022/20235.793 564 1.195 256 402 405 1.022 716 289 609 46 163 126
2023/20242.262 96 234 396 112 124 276 101 524 59 141 122 77
2024/202511.884 488 1.665 942 2.427 4.446 1.907 9 0 0 0 0 0
Totale 36.171